After the fragments encoding Cas9 and sgRNA are transfected into cells through plasmids or other means, Cas9 cuts the target genome at a specific site, causing DNA double-strand break (DSB), which is joined through nonhomologous end joining (NHEJ) or homologous recombination (HR), inserts or deletes (indel) of DNA, or relies on a homologous template containing specific mutations for targeted modification of the target site. Synbio Technologies uses amplicon sequencing to test the results of CRISPR/Cas9 genome editing, as well as to analyze off-target effects, which helps researchers quickly locate gene mutation sites and study gene functions.

• High Coverage: Each reaction can perform multiplex analysis of hundreds to thousands of amplicons.
• High Flexibility: It can be used for all kinds of mutation verification and screening genetic variation.
• Highly Customized: Analysis services can be customized.
• Cost-effective: Compared with whole-genome sequencing, it can reduce sequencing cost and turnaround time.